NEW YORK – HealthReveal, a health care technology company that anticipates and mitigates adverse medical events for people with chronic diseases, has raised $11.3 million in Series A funding. “We have an opportunity to ensure that incontrovertible medical knowledge is consistently and broadly applied by clinicians in providing evidence-based care,” said Dr. Lonny Reisman, CEO and founder of HealthReveal. The company partners with leading providers, payers and employers to guide patients to better health and preempt life-threatening occurrences through its cloud-based decision support solution that analyzes the health of at-risk patients in real-time. The company’s platform uses evidence-based medicine and continual monitoring as a foundation for machine learning to detect health risks and proactively address them to avoid costly utilization and permanent adverse health outcomes.
You are here: / / HealthReveal receives $11.3M in Series A funding